Latest news

Research & Development

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Kailera Therapeutics has provided additional details regarding its planned initial public offering, aiming to raise up to $528.5 million...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million in a Series A financing round aimed at supporting the...
Commercial

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

A new biotechnology company, Beeline Medicines, has emerged from stealth following its creation by Bristol Myers Squibb in partnership...
Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma and biotech, but it cannot replace regulatory judgment. In 2026,...
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma...
Insights

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Executive Summary Launch readiness in pharma in 2026 is defined...
Insights

What Commercial Strategy Mistakes Do Biotech Companies Make?

Executive Summary Biotech companies in 2026 most commonly fail commercially not because of weak science, but due to avoidable strategy...
Insights

The Role of AI and Data in Driving Pharma Innovation

Executive Summary AI and data are now central to driving pharma innovation in 2026, fundamentally reshaping how therapies are discovered,...
Insights

Innovation vs Regulation in Life Sciences: Can Companies Balance Both?

Innovation vs Regulation:Executive Summary Yes—life sciences companies can balance innovation and regulation in 2026, but only by integrating regulatory strategy...
Insights

Responding to Patent Expirations and Generic Competition

Executive Summary Patent expiration refers to the end of market...
Clinical

Travere’s Filspari becomes the first FDA-approved medication for FSGS

Travere Therapeutics had a long and rocky road to...
Insights

How Pharma Companies Are Adapting to Market Disruption

Executive Summary Pharma companies are adapting to market disruption in 2026 by shifting from traditional, linear operating models to integrated,...
Insights

How Is AI Transforming Market Access and Commercial Decision-Making?

AI Transforming:Executive Summary AI is transforming market access and commercial decision-making in pharma by enabling data-driven, predictive, and continuously optimized...
Insights

How Are Biotech Firms Building Resilient Innovation Pipelines?

Executive Summary Biotech firms are building resilient innovation pipelines in 2026 by shifting from single-asset, high-risk models to diversified, data-driven,...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...
Editorial Team -
Commercial

Ascletis’ ritonavir eyes marketing authorisation in Europe

Ascletis Pharma is aiming to enter the European market...
Commercial

NextCure Signs $745 Million Licensing Agreement for SIM0505 with Simcere Zaiming

NextCure has signed a licensing deal valued at up...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...
Commercial

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

A new biotechnology company, Beeline Medicines, has emerged from...
Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma...
Insights

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Executive Summary Market access challenges in pharmaceuticals in 2026 are...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -